Friday, July 31, 2026

Korean Government Faces Backlash: U.S. Report Claims Discrimination Against American Companies

Lee Jun-seok criticizes a U.S. report alleging South Korea's discrimination against American firms, urging a strong government response.

BLACKPINK’s Lisa Steals the Show at FIFA World Cup 2026 Opening Ceremony: A K-Pop Milestone

BLACKPINK's Lisa wowed fans at the 2026 FIFA World Cup opening, performing "Goals" with Anitta and Rema, marking K-pop's global rise.

Another Misfire: Machine Gun Round Fired Near North Korea

A machine gun misfire at a South Korean frontline outpost raised concerns, but no unusual North Korean activity was reported.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

Hyundai Engineering Secures $309 Million for U.S. Solar Power Plant Project in Texas

Hyundai Engineering secures $309M for Texas solar project, aiming for 200MW capacity and commercial operations by 2027.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

MSD Korea Announced at Bio Korea 2026 that Korea is a Crucial Hub for Global Innovation

Korea is now a key innovation hub for MSD, focusing on neuroscience and clinical research collaborations, with significant R&D investments.

Discover the Breakthroughs of Korea’s ARPA-H Project: 5 Key Missions for Health Security and Innovation

The K-Health Future Promotion Team showcased interim results of the Korean ARPA-H project at Bio Korea 2026, focusing on innovative healthcare solutions.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

HK inno.N partners with Atomatrix to co-develop AI-based next-generation obesity drug

HK inno.N partners with Atomatrix to develop AI-driven obesity treatments, focusing on novel small-molecule candidates.

Global AI Driven Rare Disease Diagnostics Firm 3Billion Enters the U.S. Insurance Market

3Billion is expanding globally, entering the U.S. insurance market, enhancing diagnostics, and pursuing drug development for growth.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Ulsan selected for “AI ship specialized platform” project…secures $140 million in government funding

Ulsan City secures $140M for an AI ship platform project, enhancing navigation and efficiency through software-driven technology.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.